RNA Editing - Bryant McGill

# RNA Editing **Entity class:** Concept or analytic term **Domain:** Molecular Biology / Neuroscience **Doc Type:** Scientific Concept Node **Maturity:** Established **Related:** [[U3 Molecular Data Classes]], [[Proteostasis]], [[Long-Term Memory Substrate]] --- ## Definition **RNA editing** changes RNA sequence information after transcription, potentially altering the proteins or regulatory behavior produced from a genomic template. In neural systems, RNA editing and splice variation can affect receptors, ion channels, signaling, and cellular state. ## Continuity relevance Genomic sequence alone may not specify the active molecular configuration of a neuron. A high-fidelity state model may need transcriptomic and editing context in addition to anatomy and connectivity. ## Neurotech cluster route **Collection:** [[collections/Neurotech|Neurotech]] **Source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] ## Relationships [[wiki/RNA Editing|RNA Editing]] is related to [[collections/Neurotech|Neurotech]] through [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]].  This entry's documented connections are expressed in its definition and related-work routes, with provenance retained in the source-linked material.  ## Related Work in the Corpus  - In [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], ****1.2 Mind Uploading Frameworks and Biological State Maintenance**** provides the narrative context for **RNA Editing**: Molecular and dynamical state: tractography · U3 molecular data classes · U10 thermodynamic data classes · neural plasticity · synaptogenesis · phosphorylation signaling · receptor trafficking · proteostasis · RNA editing ·…  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0326 — Established.** An infant with CPS1 deficiency received a bespoke base-editing therapy designed for his individual mutation, dosed in February 2025 — the first personalized in vivo gene-editing treatment in a human. The unit of therapy became one patient, which is a structural break with every prior drug development model. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0327 — Established.** A CHOP-and-Penn clinical-research pair designed, manufactured, and administered an individualized editing therapy inside a compressed timeline. The named individuals and their institutional pairing are the transfer mechanism by which bespoke editing became clinically real. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0330 — Established.** Prime editing writes specified sequences without double-strand breaks, making the edit a parameter rather than a redesign. When the therapeutic is a string, therapy development becomes a software-like activity with software-like iteration speed. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0331 — Established.** Base editors change single nucleotides without breaks, addressing the largest class of pathogenic variants. Roughly 350 million people live with one of about 5,000 genetic diseases, many carrying mutations unique to an individual, which defines the addressable population of individualized editing. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0332 — Established.** An IGI-led consortium received up to $27.7 million from ARPA-H to develop personalized in vivo editing for children with inborn errors. Dedicated federal funding for bespoke editing infrastructure signals that the state is building the pipeline, not merely permitting it. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0333 — Established.** The field's argument that the FDA pathway converts an economically unworkable model into a scalable clinical reality is being made by the people who built the editing tools. Practitioner advocacy shaping regulatory design is the normal mechanism by which capability becomes permitted. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0336 — Plausible.** Somatic mutation accumulation is a documented component of aging, and editing operates on exactly that class of change. A maintenance-editing program targeting high-burden tissues is the most direct translation of editing capability into longevity intervention. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0340 — Established.** Base-editing treatment of Duchenne muscular dystrophy has maintained broadly stable motor function at one year in treated boys, and in vivo exon-targeting programs have entered clinical testing. Durable functional benefit from a single in vivo edit is now observed rather than projected. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0342 — Strongly indicated.** Off-target assessment is the central safety science of editing, and it improves with sequencing depth and prediction models. The safety bar is therefore falling in cost at the same rate as sequencing, which quietly expands what is approvable. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0343 — Established.** A death following experimental base editing for a nonfatal neurodevelopmental disorder in China in 2026 marks the boundary between acceptable and unacceptable risk in non-life-threatening indications. Boundary events shape international regulatory posture more than successes do. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0345 — Established.** AI-engineered base editors are being distributed through access programs, meaning the editing enzyme itself is now a designed rather than discovered object. Designed enzymes shorten the loop between a target specification and a working tool to weeks. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0346 — Analytic.** When the enzyme is designed, the guide is a string, and delivery is a formulation, the whole therapeutic becomes a computationally specified artifact. The iteration loop for medicine begins to resemble the iteration loop for software, which changes its improvement rate. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0348 — Unresolved.** Somatic editing is broadly permitted while heritable editing is broadly prohibited, and the boundary depends on delivery specificity that improves continuously. Resolution will come through a jurisdictional divergence rather than an international agreement. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0349 — Plausible.** Every editing capability approved for disease establishes a technique that applies equally to non-disease variation. Indication expansion is the ordinary life cycle of medical technology, and there is no mechanism in the approval system designed to stop it at the disease boundary. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]]